Martha E. Lyon

1.4k total citations
60 papers, 950 citations indexed

About

Martha E. Lyon is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Martha E. Lyon has authored 60 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Pediatrics, Perinatology and Child Health and 11 papers in Epidemiology. Recurrent topics in Martha E. Lyon's work include Diabetes Management and Research (15 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers) and Neonatal Health and Biochemistry (10 papers). Martha E. Lyon is often cited by papers focused on Diabetes Management and Research (15 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers) and Neonatal Health and Biochemistry (10 papers). Martha E. Lyon collaborates with scholars based in Canada, United States and Belgium. Martha E. Lyon's co-authors include Andrew W. Lyon, J. Decker Butzner, Patricia K. Doyle–Baker, Allison A. Venner, Yacov Rabi, Cynthia Trevenen, Dominica Gidrewicz, Jeffrey A. DuBois, Stephen Wainer and Alex Chin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PEDIATRICS.

In The Last Decade

Martha E. Lyon

58 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha E. Lyon Canada 19 215 201 163 162 160 60 950
P Royle United Kingdom 6 207 1.0× 268 1.3× 64 0.4× 282 1.7× 54 0.3× 6 1.0k
Neil Hawkes United Kingdom 16 166 0.8× 307 1.5× 140 0.9× 54 0.3× 45 0.3× 74 844
Otilia Mărginean Romania 14 159 0.7× 100 0.5× 62 0.4× 81 0.5× 79 0.5× 54 686
Rousseau Gama United Kingdom 21 228 1.1× 258 1.3× 36 0.2× 460 2.8× 71 0.4× 131 1.6k
Praveen K. Potukuchi United States 19 65 0.3× 185 0.9× 207 1.3× 130 0.8× 50 0.3× 53 1.1k
Gabriele Halwachs‐Baumann Austria 20 399 1.9× 143 0.7× 23 0.1× 156 1.0× 184 1.1× 51 1.4k
Mahboob Lessan‐Pezeshki Iran 22 213 1.0× 200 1.0× 29 0.2× 44 0.3× 129 0.8× 64 1.2k
Joan R. Jacobs United States 17 204 0.9× 152 0.8× 20 0.1× 110 0.7× 249 1.6× 28 1.3k
Eytan Cohen Israel 18 139 0.6× 181 0.9× 22 0.1× 101 0.6× 67 0.4× 49 949

Countries citing papers authored by Martha E. Lyon

Since Specialization
Citations

This map shows the geographic impact of Martha E. Lyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha E. Lyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha E. Lyon more than expected).

Fields of papers citing papers by Martha E. Lyon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha E. Lyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha E. Lyon. The network helps show where Martha E. Lyon may publish in the future.

Co-authorship network of co-authors of Martha E. Lyon

This figure shows the co-authorship network connecting the top 25 collaborators of Martha E. Lyon. A scholar is included among the top collaborators of Martha E. Lyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha E. Lyon. Martha E. Lyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyon, Martha E. & Andrew W. Lyon. (2021). N-Acetylcysteine Interference with a Glucose Dehydrogenase Linked Glucose Meter. Journal of Diabetes Science and Technology. 16(5). 1114–1119. 7 indexed citations
2.
Lyon, Martha E., et al.. (2020). Accuracy in Measuring Racial Disparities during the COVID-19 Pandemic Needs Improvement. The Journal of Applied Laboratory Medicine. 6(1). 310–313. 4 indexed citations
3.
Truong, Tony H., et al.. (2020). Chemotherapy readiness in pediatric oncology. Hematology/Oncology and Stem Cell Therapy. 14(2). 110–113.
4.
Lyon, Andrew W. & Martha E. Lyon. (2019). Evaluation of Precision and Bias Specifications Required to Achieve the 2018 FDA Guidance Criteria for Glucose Meter Performance Using Simulation Models. Journal of Diabetes Science and Technology. 14(3). 513–518. 2 indexed citations
5.
Inman, Mark D., et al.. (2019). A Simulation Study to Assess the Effect of Analytic Error on Neonatal Glucose Measurements Using the Canadian Pediatric Society Position Statement Action Thresholds. Journal of Diabetes Science and Technology. 14(3). 519–525. 5 indexed citations
6.
Wang, Li, et al.. (2017). Limitations and opportunities of whole blood bilirubin measurements by GEM premier 4000®. BMC Pediatrics. 17(1). 92–92. 8 indexed citations
7.
Lyon, Martha E., et al.. (2015). The clinical impact of implementing the Roche® bilirubin total Gen.3 method on neonate phototherapy. Clinical Biochemistry. 48(16-17). 1171–1173. 5 indexed citations
8.
Gidrewicz, Dominica, Kathryn J. Potter, Cynthia Trevenen, Martha E. Lyon, & Decker Butzner. (2015). Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population. The American Journal of Gastroenterology. 110(5). 760–767. 53 indexed citations
9.
Stoian, Cristina, Martha E. Lyon, Robin G. Cox, David Stephure, & Jean K. Mah. (2011). Vitamin D concentrations among healthy children in Calgary, Alberta. Paediatrics & Child Health. 16(2). 82–86. 25 indexed citations
10.
Lyon, Martha E. & Andrew W. Lyon. (2011). Patient acuity exacerbates discrepancy between whole blood and plasma methods through error in molality to molarity conversion: “Mind the gap!”. Clinical Biochemistry. 44(5-6). 412–417. 19 indexed citations
11.
Lyon, Martha E., Dale F. Gray, Leland B. Baskin, Jeffrey A. DuBois, & Andrew W. Lyon. (2010). A mathematical model to assess the influence of hematocrit on point of care glucose meter performance. Clinical Biochemistry. 43(10-11). 905–909. 12 indexed citations
12.
Lyon, Martha E., et al.. (2008). Evaluation of the Bayer® microalbumin/creatinine urinalysis dipstick. Clinica Chimica Acta. 393(2). 110–113. 10 indexed citations
13.
Kalt, Wilhelmina, et al.. (2007). Effect of blueberry feeding on plasma lipids in pigs. British Journal Of Nutrition. 100(1). 70–78. 50 indexed citations
14.
Bamforth, Fiona, et al.. (2006). B-type natriuretic peptide in pediatrics. Clinical Biochemistry. 39(6). 600–605. 28 indexed citations
15.
Lyon, Martha E., et al.. (2004). Effect of hemolysis on cardiac troponin T determination by the Elecsys® 2010 immunoanalyzer. Clinical Biochemistry. 37(8). 698–701. 23 indexed citations
18.
Lyon, Andrew W., et al.. (1997). Use of thrombin inhibitors ex vivo allows critical care clinical chemistry and hematology testing on common specimens. Clinical Biochemistry. 30(2). 121–127. 8 indexed citations
20.
Lyon, Martha E., et al.. (1995). Specific heparin preparations interfere with the simultaneous measurement of ionized magnesium and ionized calcium. Clinical Biochemistry. 28(1). 79–84. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026